Identification of key metabolic changes during liver fibrosis progression in rats using a urine and serum metabolomics approach.

about

Ursodeoxycholic acid improves liver function via phenylalanine/tyrosine pathway and microbiome remodelling in patients with liver dysfunction

P2860

Q58796002-3F8AE1E4-A5B0-4953-8FA5-2D5E96BA732C

P2860

Identification of key metabolic changes during liver fibrosis progression in rats using a urine and serum metabolomics approach.

Item

http://www.wikidata.org/entity/Q41200837

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Identification of key metaboli ...... d serum metabolomics approach.

@en

type

Item

label

Identification of key metaboli ...... d serum metabolomics approach.

@en

prefLabel

Identification of key metaboli ...... d serum metabolomics approach.

@en

P1476

Identification of key metaboli ...... d serum metabolomics approach.

@en

P2093

Fang Lu

http://www.w3.org/2001/XMLSchema#string

Hong Chang

http://www.w3.org/2001/XMLSchema#string

Hong-Yu Meng

http://www.w3.org/2001/XMLSchema#string

Hong-Yu Wang

http://www.w3.org/2001/XMLSchema#string

Shu-Min Liu

http://www.w3.org/2001/XMLSchema#string

Xiao-Xu Yang

http://www.w3.org/2001/XMLSchema#string

Yu Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Data, information, knowledge and principle: back to metabolism in KEGG

Role of Sphingolipids in the Pathobiology of Lung Inflammation

Nuclear magnetic resonance based metabolomics and liver diseases: Recent advances and future clinical applications

Liver fibrosis: mechanisms of immune-mediated liver injury

Biomarkers in nonalcoholic fatty liver disease

'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data

Evolving therapies for liver fibrosis.

Metabolic characterization of the early stage of hepatic fibrosis in rat using GC-TOF/MS and multivariate data analyses.

Plasma sphingolipids as potential indicators of hepatic necroinflammation in patients with chronic hepatitis C and normal alanine aminotransferase level.

L-tryptophan-mediated enhancement of susceptibility to nonalcoholic fatty liver disease is dependent on the mammalian target of rapamycin

P2888

s41598-017-11759-z

P304

11433

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-11759-Z

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28900168

http://www.w3.org/2001/XMLSchema#string

P932

5595818

http://www.w3.org/2001/XMLSchema#string

Identification of key metabolic changes during liver fibrosis progression in rats using a urine and serum metabolomics approach.

about

P2860

P2860

Identification of key metabolic changes during liver fibrosis progression in rats using a urine and serum metabolomics approach.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P698

P932